2025 & 2026 Archive
Our monthly newsletters provide timely insights into the global fight against antimicrobial resistance (AMR), alongside updates on our funding initiatives, research highlights, and partner activities. Each edition brings together the latest developments from across our network — from innovative research and policy discussions to stories from our grantees and collaborators working on the frontlines of AMR prevention. Whether you are a researcher, policymaker, healthcare professional, or advocate, our newsletters are designed to keep you informed, engaged, and connected to progress in this critical area of global health.
February 2025
This edition highlights key global developments in antimicrobial resistance, including progress toward the WHO European Programme of Work (2026–2030), analysis of potential impacts from changes to U.S. foreign aid, and new funding opportunities such as the £1 million Trinity Challenge. It also covers innovation in AMR detection through space research, outcomes from the UN General Assembly High-Level Meeting on AMR, and upcoming sector events. Read the full newsletter → Link
March 2025
This edition highlights major global developments in antimicrobial resistance, including breakthroughs in rapid diagnostic testing such as ShanX Medtech’s 1-hour antimicrobial susceptibility system, and McGill University’s 36-minute bacterial testing innovation. It also explores new global research on AMR governance across 193 countries, discoveries of antibiotic-resistant ancient bacteria with potential biomedical applications, and evolving approaches to infection management in wound care. Together, these stories reflect growing innovation, governance efforts, and the urgent need for faster, more targeted antimicrobial decision-making. Read the full newsletter → Link
October 2025
This edition features key global developments in antimicrobial resistance, including the launch of the WHO GLASS 2025 surveillance report, new digital innovations to improve antibiotic access and supply chains, updates on the Trinity Challenge, and emerging rapid diagnostic technologies designed to transform infection treatment. It also highlights WHO policy guidance supporting national AMR action plans and health system strengthening.
🔗 Read the full newsletter → Link
November 2025
This special edition reflects on World Antimicrobial Awareness Week, highlighting global actions and commitments to combat antimicrobial resistance. It features PAR Foundation’s international video competition (39 entries across 8 countries), calls to action from the World Health Organization, and renewed momentum from global partners including United Nations Environment Programme and the Quadripartite alliance. The edition also celebrates milestones such as the Fleming Fund and showcases advocacy initiatives turning awareness into action.
🔗 Read the full newsletter → Link
December 2025
This final edition of the year highlights key global developments in antimicrobial resistance, including renewed calls from the World Health Organization and partners to translate political commitments into action following World Antimicrobial Awareness Week. It also features national capacity strengthening efforts such as WHO-supported AMR missions in Angola, new antibiotic treatment advances for gonorrhoea approved by the U.S. FDA, and updates on EU-funded One Health AMR initiatives. The edition further highlights new global forecasts warning of the long-term burden of AMR-related mortality, underscoring the urgent need for coordinated action across health systems, agriculture, and policy. Read the full newsletter → Link
January 2026
This edition opens the year with key global developments in antimicrobial resistance, including advances in AI-driven antibiotic discovery, new funding calls focused on innovative chemistry for AMR, and major international scientific and policy meetings. It also highlights global leadership and training programmes aimed at strengthening AMR capacity, alongside new research into extensively drug-resistant infections and emerging surveillance challenges. Read the full newsletter → Link
February 2026
This edition of the year highlights key global developments in antimicrobial resistance, including renewed calls from the World Health Organization and partners to translate political commitments into action following World Antimicrobial Awareness Week. It also features national capacity strengthening efforts such as WHO-supported AMR missions in Angola, new antibiotic treatment advances for gonorrhoea approved by the U.S. FDA, and updates on EU-funded One Health AMR initiatives. The edition further highlights new global forecasts warning of the long-term burden of AMR-related mortality, underscoring the urgent need for coordinated action across health systems, agriculture, and policy. Read the full newsletter → Link
March 2026
This edition highlights major global developments in antimicrobial resistance, including breakthroughs in rapid diagnostic testing that significantly reduce time to appropriate treatment, new evidence on AMR governance across countries, and emerging research on drug-resistant organisms found in extreme environments. It also explores advances in wound care approaches aimed at reducing antimicrobial overuse and improving infection management in an AMR-conscious future.
🔗 Read the full newsletter → Link
April 2026
April 2026 highlights key progress and challenges in the global fight against antimicrobial resistance. Nepal strengthened diagnostic capacity through training in fungal identification and antifungal susceptibility testing. Nigeria will host the 5th High-Level Ministerial Meeting on AMR in Abuja, bringing together over 100 countries for the first time in Africa. In Ethiopia, Jimma University is advancing locally produced antibiotic testing tools to improve surveillance and reduce import dependence. New oral antibiotics for gonorrhoea have been approved, offering rare treatment advances amid rising resistance. A global governance study across 193 countries underscores uneven progress, while reports warn of declining antibiotic development and a growing AMR burden.
🔗 Read the full newsletter → Link
Subscribe to Our Newsletter
Stay informed with the latest insights on antimicrobial resistance, funding opportunities, and global health developments.
By subscribing, you will receive regular updates featuring:
• Research and innovation highlights
• Updates from our grantees and partners
• New funding calls and opportunities
• Insights on AMR prevention and policy
Subscribe here
